For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Element Biosciences, Inc.

USPTO Granted Patents = 41

EPO Patents = 5

Forward Citations = 368

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Michael Previte (28 out of 60 patents)

Matthew William Kellinger (24 out of 40 patents)

Chunhong Zhou (20 out of 39 patents)

4. Molly Min He (18 out of 59 patents)

5. Sinan Arslan (18 out of 19 patents)

6. Junhua Zhao (15 out of 17 patents)

7. Minghao Guo (13 out of 15 patents)

8. Steve Xiangling Chen (10 out of 11 patents)

9. William Light (10 out of 10 patents)

10. Derek Fuller (8 out of 11 patents)

11. Tyler Lopez (8 out of 8 patents)

12. Samantha Snow (7 out of 10 patents)

13. Hua Yu (7 out of 9 patents)

14. Mark R Ambroso (6 out of 13 patents)

15. Michael Klein (6 out of 6 patents)

Core Competencies:

Nucleic Acid Sequencing

Polymerase-Nucleotide Conjugates

Nucleic Acid Nanostructures

Engineered Polymerases

Fluorescence Imaging

Multivalent Binding Composition

Double-Stranded Splint Adaptors

Circular Nucleic Acid Molecules

Flow Cell Devices

Reverse Transcriptase

Genomic Testing Assays

Single-Pass Primary Analysis

41 patents: Sort by Forward Citations

1. 12421545 - Compositions and methods for preparing nucleic acid nanostructures using compaction oligonucleotides (2025-09-23),

2. 12391929 - Polymerase-nucleotide conjugates for sequencing by trapping (2025-08-19),

3. 12371743 - Double-stranded splint adaptors and methods of use (2025-07-29),

4. 12365892 - Double-stranded splint adaptors with universal long splint strands and methods of use (2025-07-22),

5. 12359193 - Single-stranded splint strands and methods of use (2025-07-15),

6. 12331356 - Multipart reagents having increased avidity for polymerase binding (2025-06-17),

7. 12313627 - Multivalent binding composition for nucleic acid analysis (2025-05-27),

8. 12270056 - Engineered polymerases (2025-04-08),

9. 12241891 - Multivalent binding composition for nucleic acid analysis (2025-03-04),

10. 12163163 - Engineered polymerases with reduced sequence-specific errors (2024-12-10),

11. 12146190 - Optical systems for nucleic acid sequencing and methods thereof (2024-11-19),

12. 12139727 - Engineered polymerases (2024-11-12),

13. 12134766 - Methods for generating circular nucleic acid molecules (2024-11-05),

14. 12091657 - Reverse transcriptase for nucleic acid sequencing (2024-09-17),

15. 12006518 - Engineered polymerases with reduced sequence-specific errors (2024-06-11),

Element Biosciences is developing a new DNA sequencing platform with the goal of enabling comprehensive genome analysis at unprecedented scale. The company aims to accelerate scientific research and discovery by providing researchers with technology that delivers highly accurate genomic information in a cost-effective manner. Element Biosciences is committed to advancing genomics to better understand human health and address complex diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

41 Patents

#142 in San Diego, CA

#1,930 in California

#8,166 in US

#16,217 in the World

San Diego, CA, United States of America

Element Biosciences, Inc.

Forward Citations = 368

41 inventors:

Michael Previte (28 out of 60 patents)

Matthew William Kellinger (24 out of 40 patents)

Chunhong Zhou (20 out of 39 patents)

4. Molly Min He (18 out of 59 patents)

5. Sinan Arslan (18 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…